We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESS icon
1526
Essex Property Trust
ESS
$18.9B
$1.64M 0.01%
5,462
-10,822
-66% -$3.19M
CRM icon
1527
CALL
Salesforce
CRM
$149B
$1.64M 0.01%
6,700
-12,400
-65% -$2.86M
HIG icon
1528
Hartford Financial Services
HIG
$39.3B
$1.64M 0.01%
26,424
-23,953
-48% -$1.57M
CTRN icon
1529
Citi Trends
CTRN
$559M
$1.64M 0.01%
18,786
+13,988
+292% +$1.29M
PSEC icon
1530
Prospect Capital
PSEC
$1.12B
$1.64M 0.01%
+194,931
New +$1.63M
INVH icon
1531
Invitation Homes
INVH
$17.9B
$1.63M 0.01%
43,795
-70,347
-62% -$2.49M
ATIP.WS
1532
CALL
DELISTED
ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ATIP.WS
$1.63M 0.01%
+170,875
New +$384K
TRCA.WS
1533
CALL
DELISTED
Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TRCA.WS
$1.63M 0.01%
+168,725
New +$126K
NBN icon
1534
Northeast Bank
NBN
$1.08B
$1.63M 0.01%
54,444
+45,751
+526% +$1.31M
ARBGW
1535
CALL
DELISTED
Aequi Acquisition Corp warrants
ARBGW
$1.63M 0.01%
166,661
PPC icon
1536
Pilgrim's Pride
PPC
$7.09B
$1.62M 0.01%
+73,234
New +$1.74M
VLRS
1537
Controladora Vuela Compania de Aviacion
VLRS
$910M
$1.62M 0.01%
84,507
-7,151
-8% -$122K
MTTRW
1538
CALL
DELISTED
Matterport, Inc. Warrant
MTTRW
$1.62M 0.01%
+100,000
New +$427K
POWRW
1539
CALL
DELISTED
Powered Brands Warrants
POWRW
$1.62M 0.01%
166,660
ADVWW
1540
CALL
DELISTED
Advantage Solutions Warrant
ADVWW
$1.62M 0.01%
149,999
TZPSW
1541
CALL
DELISTED
TZP Strategies Acquisition Corp. Warrant
TZPSW
$1.62M 0.01%
166,658
SYRS
1542
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.61M 0.01%
+29,641
New +$1.75M
VGII.WS
1543
CALL
DELISTED
Virgin Group Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one Class
VGII.WS
$1.61M 0.01%
+164,996
New +$194K
IXC icon
1544
iShares Global Energy ETF
IXC
$2.68B
$1.61M 0.01%
+60,694
New +$1.58M
CAMT icon
1545
Camtek
CAMT
$6.53B
$1.61M 0.01%
+42,682
New +$1.45M
NRACW
1546
CALL
DELISTED
Northern Revival Acquisition Corporation Warrant
NRACW
$1.61M 0.01%
+166,632
New +$121K
AFYA icon
1547
Afya
AFYA
$1.32B
$1.61M 0.01%
62,441
-65,714
-51% -$1.55M
EXLS icon
1548
EXL Service
EXLS
$4.66B
$1.61M 0.01%
75,780
+39,265
+108% +$779K
CHAA.WS
1549
CALL
DELISTED
Catcha Investment Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CHAA.WS
$1.61M 0.01%
+166,661
New +$128K
FINMW
1550
CALL
DELISTED
Marlin Technology Corporation Warrant
FINMW
$1.6M 0.01%
165,776

Similar funds

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.